Former Sudbury med research boss returns to his roots.

Dr. Francisco Diaz-Mitoma, the former CEO of Sudbury's Advanced Medical Research Institute of Canada (AMRIC), has been appointed chief medical officer of VBI Vaccines (VBI) in Cambridge, Mass.

Diaz-Mitoma will oversee clinical development initiatives at VBI, originally called Variation Biotechnologies, the company he co-founded in 2001.

Last November, Diaz-Mitoma abruptly resigned from his position at AMRIC, the research arm of Health Sciences North. Hospital officials did not comment on his departure at the time, saying only it was a personal matter.

Soon after Diaz Mitoma's departure AMRIC was rebranded as the Health Sciences North Research Institute with a renewed focus on health issues that affect Northerners.

"We're excited to welcome Dr. Diaz-Mitoma back to VBI as a key addition to our management team," said Jeff Baxter, VBI's president-CEO, in a July 25 statement. "Francisco brings significant immunology, vaccine development, and hepatitis B ex perience. His appointment, and other new recent hires, greatly increases VBI's clinical development capability as we progress late stage clinical development plans for Sci-B-Vac, our hepatitis B vaccine, in Europe and North America, as well as other vaccine candidates in our...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT